AstraZeneca
The partners will develop and clinically validate an AI tool that integrates into EHRs to accelerate the diagnosis of hypophosphatasia, a rare genetic bone disorder.
Also, Indian diagnostics chain Redcliffe Labs has rolled out a mobile diabetes risk calculation feature.
The alliance aims to improve gBRCA identification and increase entry to new treatment options.
Sonny Shergill, vice president of commercial digital health at AstraZeneca, highlights pharma's perspective on digital health investments and partnerships for sector growth.
Patients in Switzerland will have access to Mika Health's psychological support offerings in conjunction with pharmaceutical therapy.
The companies will leverage Absci's AI-enabled Integrated Drug Creation platform and the pharma giant's oncology research and development expertise.
The pharma giant's new health tech company will operate as a separate business and scale the company's already established digital technologies to enhance clinical trials.
The partners created a registry to generate real-world data using consenting U.S. patients' medical records to further research in stage 1 to 3 breast cancer.
Also, CureApp is getting $77 million in investment from the Sawai Group as part of their license deal.
![[Left] Ed Deng, co-founder and CEO, Health2Sync; and [Right] Claudio Longo, President, AstraZeneca Taiwan](/sites/mhn/files/styles/230x130/public/2025-07/%2528Left%2529%2520Ed%2520Deng%252C%2520Co-founder%2520and%2520CEO%2520of%2520Health2Sync%2520and%2520%2528Right%2529%2520Claudio%2520Longo%252C%2520President%2520of%2520AstraZeneca%2520Taiwan.jpg?itok=XO7M1UnC)
Health2Sync has upgraded its patient management platform to identify patients' CKD risk levels.